PMID- 28450866 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 1664-3224 (Print) IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 8 DP - 2017 TI - Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation. PG - 434 LID - 10.3389/fimmu.2017.00434 [doi] LID - 434 AB - The presence of donor human leukocyte antigen (HLA)-specific antibodies has been shown to be associated with graft loss and decreased patient survival, but it is not uncommon that donor-specific HLA antibodies are absent in patients with biopsy-proven antibody-mediated rejection. In this review, we focus on the latest findings on antibodies against non-HLA antigens in kidney and heart transplantation. These non-HLA antigens include myosin, vimentin, Kalpha1 tubulin, collagen, and angiotensin II type 1 receptor. It is suggested that the detrimental effects of HLA antibodies and non-HLA antibodies synergize together to impact graft outcome. Injury of graft by HLA antibodies can cause the exposure of neo-antigens which in turn stimulate the production of antibodies against non-HLA antigens. On the other hand, the presence of non-HLA antibodies may increase the risk for a patient to develop HLA-specific antibodies. These findings indicate it is imperative to stratify the patient's immunologic risk by assessing both HLA and non-HLA antibodies. FAU - Zhang, Xiaohai AU - Zhang X AD - HLA and Immunogenetics Laboratory, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. FAU - Reinsmoen, Nancy L AU - Reinsmoen NL AD - HLA and Immunogenetics Laboratory, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. LA - eng PT - Journal Article PT - Review DEP - 20170413 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 PMC - PMC5389972 OTO - NOTNLM OT - angiotensin II type 1 receptor antibody OT - heart transplant OT - human leukocyte antigen OT - kidney transplant OT - non-human leukocyte antigen antibody EDAT- 2017/04/30 06:00 MHDA- 2017/04/30 06:01 PMCR- 2017/01/01 CRDT- 2017/04/29 06:00 PHST- 2016/10/17 00:00 [received] PHST- 2017/03/28 00:00 [accepted] PHST- 2017/04/29 06:00 [entrez] PHST- 2017/04/30 06:00 [pubmed] PHST- 2017/04/30 06:01 [medline] PHST- 2017/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2017.00434 [doi] PST - epublish SO - Front Immunol. 2017 Apr 13;8:434. doi: 10.3389/fimmu.2017.00434. eCollection 2017.